1-4 of 4
Catherine Sautès-Fridman
Close
Sort by
Journal Articles

Ublituximab (TGTX-1101), a Novel, Third-Generation Anti-CD20 Antibody Demonstrates Enhanced Antitumor Activity Compared to Rituximab in Primary CNS and Intraocular Lymphoma Murine Models.

Sabrina Donnou, Rym Ben Abdelwahed-Bagga, Jérémie Cosette, Hanane Ouakrim, Lucile Crozet, Alexandra Jacquet, Wolf Herman Fridman, Catherine Sautès-Fridman, Peter Sportelli, Remi Urbain, Sylvain Fisson
Journal: Blood
Blood (2012) 120 (21): 2755.
https://doi.org/10.1182/blood.V120.21.2755.2755
Published: 2012
Journal Articles

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Clinical Trials & Observations
Sophie Camilleri-Broët, Emmanuelle Crinière, Philippe Broët, Vincent Delwail, Karima Mokhtari, Anne Moreau, Michèle Kujas, Martine Raphaël, Wafae Iraqi, Catherine Sautès-Fridman, Philippe Colombat, Khê Hoang-Xuan, Antoine Martin
Journal: Blood
Blood (2006) 107 (1): 190–196.
https://doi.org/10.1182/blood-2005-03-1024
Published: 2006
Journal Articles

Long-lived immature dendritic cells mediated by TRANCE-RANK interaction

Isabelle Cremer, Marie-Caroline Dieu-Nosjean, Sylvie Maréchal, Colette Dezutter-Dambuyant, Sarah Goddard, David Adams, Nathalie Winter, Christine Menetrier-Caux, Catherine Sautès-Fridman, Wolf H. Fridman, Chris G. F. Mueller
Journal: Blood
Blood (2002) 100 (10): 3646–3655.
https://doi.org/10.1182/blood-2002-01-0312
Published: 2002
Journal Articles

Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism

Fabrice Benchetrit, Arnaud Ciree, Virginie Vives, Guy Warnier, Alain Gey, Catherine Sautès-Fridman, François Fossiez, Nacilla Haicheur, Wolf H. Fridman, Eric Tartour
Journal: Blood
Blood (2002) 99 (6): 2114–2121.
https://doi.org/10.1182/blood.V99.6.2114
Published: 2002